Literature DB >> 24166015

[Importance of neurobiology for modular psychotherapy].

C Schmahl1, M Bohus.   

Abstract

In the context of continuing education in psychiatry and psychotherapy, modular psychotherapy is of special importance. In modular psychotherapy, general interventions, e.g. for regulation of emotions, have an important function. In this review examples are given to describe the importance of neurobiology for the understanding and the improvement of these mechanisms. In addition, the use of neurobiological investigations within classical psychotherapy trials in the fields of borderline personality disorder and posttraumatic stress disorder will be depicted.

Entities:  

Mesh:

Year:  2013        PMID: 24166015     DOI: 10.1007/s00115-013-3872-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  27 in total

1.  Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study.

Authors:  S C Herpertz; T M Dietrich; B Wenning; T Krings; S G Erberich; K Willmes; A Thron; H Sass
Journal:  Biol Psychiatry       Date:  2001-08-15       Impact factor: 13.382

2.  [Dissociative symptoms during treatment of borderline personality disorder].

Authors:  Diana Braakmann; Sonia Ludewig; Jork Milde; Christian E Stiglmayr; Michael Hüppe; Valerija Sipos; Ulrich Schweiger
Journal:  Psychother Psychosom Med Psychol       Date:  2007 Mar-Apr

3.  Changes in hippocampal volume in patients with post-traumatic stress disorder after sertraline treatment.

Authors:  Letizia Bossini; Maricla Tavanti; Alessia Lombardelli; Sara Calossi; Nicola Riccardo Polizzotto; Rosita Galli; Giampaolo Vatti; Fulvio Pieraccini; Paolo Castrogiovanni
Journal:  J Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.153

4.  Aversive tension in patients with borderline personality disorder: a computer-based controlled field study.

Authors:  C E Stiglmayr; T Grathwol; M M Linehan; G Ihorst; J Fahrenberg; M Bohus
Journal:  Acta Psychiatr Scand       Date:  2005-05       Impact factor: 6.392

5.  Effects of psychotherapy on regional cerebral blood flow during trauma imagery in patients with post-traumatic stress disorder: a randomized clinical trial.

Authors:  R J L Lindauer; J Booij; J B A Habraken; E P M van Meijel; H B M Uylings; M Olff; I V E Carlier; G J den Heeten; B L F van Eck-Smit; B P R Gersons
Journal:  Psychol Med       Date:  2007-09-06       Impact factor: 7.723

6.  Police officers under attack: resilience implications of an fMRI study.

Authors:  Julio F P Peres; Bernd Foerster; Leandro G Santana; Mauricio Domingues Fereira; Antonia G Nasello; Mariângela Savoia; Alexander Moreira-Almeida; Henrique Lederman
Journal:  J Psychiatr Res       Date:  2010-12-14       Impact factor: 4.791

7.  Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings.

Authors:  Christian Schmahl; Wolfgang Greffrath; Ulf Baumgärtner; Tanja Schlereth; Walter Magerl; Alexandra Philipsen; Klaus Lieb; Martin Bohus; Rolf-Detlef Treede
Journal:  Pain       Date:  2004-07       Impact factor: 6.961

8.  A cross-sectional investigation of discontinuation of self-injury and normalizing pain perception in patients with borderline personality disorder.

Authors:  P Ludäscher; W Greffrath; C Schmahl; N Kleindienst; A Kraus; U Baumgärtner; W Magerl; R-D Treede; M Bohus
Journal:  Acta Psychiatr Scand       Date:  2009-01-07       Impact factor: 6.392

9.  Pain perception in self-injurious patients with borderline personality disorder.

Authors:  M J Russ; S D Roth; A Lerman; T Kakuma; K Harrison; R D Shindledecker; J Hull; S Mattis
Journal:  Biol Psychiatry       Date:  1992-09-15       Impact factor: 13.382

10.  Functional connectivity of pain-mediated affect regulation in Borderline Personality Disorder.

Authors:  Inga Niedtfeld; Peter Kirsch; Lars Schulze; Sabine C Herpertz; Martin Bohus; Christian Schmahl
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.